SISC

Società Italiana per lo Studio delle Cefalee

SISC

Società Italiana per lo Studio delle Cefalee

Centro Regionale Diagnosi e Cura delle Cefalee

Tipologia struttura Centro Regionale
Direttore della struttura Dott.ssa Grazia Sances
Fondatore Prof. Giuseppe Nappi
Responsabile Dott.ssa Grazia Sances
Prof.ssa Cristina Tassorelli
Collaboratori Dott.ssa Elena Guaschino
Dott.ssa Natascia Ghiotto
Prof. Alfredo Costa
Dott. Roberto De Icco
Dott.ssa Alessia Putorti'
Marta Allena
Daniele Martinelli
Direttori / responsabili precedenti Prof. Giuseppe Nappi

Informazioni

  • 0382 380207
  • 0382 3801
  • 0382 380286
Orari di apertura del centro informazioni
Lunedì 10:00 - 12:00
Martedì 10:00 - 12:00
Venerdì 10:00 - 12:00

Indirizzo

  • Via Mondino 2
    27100 Pavia (PV)
(avvia il navigatore ›)

Prenotazioni

  • 0382 380232
  • 0382 380315
È possibile prenotare nei seguenti orari
Lunedì 08:30 - 13:00
Martedì 08:30 - 13:00
Mercoledì 08:30 - 13:00
Giovedì 08:30 - 13:00
Venerdì 08:30 - 13:00

Visite

Le visite vengono effettuate secondo gli orari seguenti
Lunedì 10:00 - 12:30
Martedì 09:45 - 12:35 13:30 - 16:00
Mercoledì 09:45 - 12:35
Giovedì 10:00 - 13:30 14:00 - 17:00
Venerdì 09:30 - 13:00
Tipologia di attività Visita specialistica
Visita di controllo
Test psicometrici
Test genetici
Disassuefazione dagli analgesici
Attività informativa per il paziente
Visite per cefalee dell'età evolutiva SI

Altre informazioni

ATTIVITÀ ASSISTENZIALE DEL CENTRO
Numero di prime visite per anno 1700
Numero di visite di controllo per anno 1900
Possibilità di ricovero SI
Day-hospital/Day service/Prestazione ambulatoriali complesse SI
Prestazioni terapeutiche Agopuntura
Neurostimolazione non-invasiva
Psicoterapia
Terapia del dolore
Tossina botulinica
ATTIVITÀ FORMATIVA DEL CENTRO
Sede formativa per corso di laurea in medicina SI
Sede formativa per corso di laurea professione sanitarie SI
Sede formativa per scuole di Specializzazione SI
Sede di attività per Dottorato di Ricerca SI
Sede di Master per le Cefalee NO
ATTIVITÀ SCIENTIFICA DEL CENTRO
Elenco pubblicazioni nell'ambito delle cefalee negli ultimi 5 anni:
De Icco R, Perrotta A, Grillo V, Cosentino G, Sances G, Sandrini G, Tassorelli C. Experimentally-induced spinal nociceptive sensitization increases with migraine frequency: a single-blind controlled study. Pain 2019
Greco R, Demartini C, Zanaboni AM, Tumelero E, Reggiani A, Misto A, Piomelli D, Tassorelli C. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study. Neurobiol Dis 2019:104624
Viana M, De Icco R, Allena M, Sances G, Højland JR, Katsarava Z, Lainez MJA, Fadic R, Goicochea MT, Nappi G, Tassorelli C. Comoestas Consortium. Clinical Subtypes of Medication Overuse Headache - Findings From a Large Cohort. Headache 2019; 59 (9): 1481-91
Viana M, Khaliq F, Zecca C, Figuerola ML, Sances G, Di Piero V, Petolicchio B, Alessiani M, Geppetti P, Lupi C, Benemei S, Iannacchero R, Maggioni F, Jurno ME, Odobescu S, Chiriac E, Marfil A, Brighina F, Barrientos Uribe N, Pérez Lago C, Bordini C, Lucchese F, Maffey V, Nappi G, Sandrini G, Tassorelli C. Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol 2019
Ashina M, Vasudeva R, Jin L, Lombard L, Gray E, Doty EG, Yunes-Medina L, Kinchen KS, Tassorelli C. Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies. Headache 2019
Tassorelli C, De Icco R. Getting closer to a cure for migraine. Nat Rev Neurol 2019
De Icco R, Tassorelli C. Dissecting out migraine complexity through comprehensive analysis of allodynia. Brain 2019; 142 (1): 5-8
Galli F, Tanzilli A, Simonelli A, Tassorelli C, Sances G, Parolin M, Cristofalo P, Gualco I, Lingiardi V. Personality and Personality Disorders in Medication-Overuse Headache: A Controlled Study by SWAP-200. Pain Res Manag.2019; 2019:1874078
Deen M, Martinelli D, Pijpers J, Diener HC, Silberstein S, Ferrari MD, Ashina M, Tassorelli C, Yuan H. Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults. Cephalalgia 2019; 39(8):1058-66
Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J; International Headache Society Clinical Trials Standing Committee. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. Cephalalgia 2019: 39(6):687-710
Abu-Arafeh I, Hershey AD, Diener HC, Tassorelli C; Clinical Trials Standing Committee and the Child and Adolescent Standing Committee of the International Headache Society Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition. Cephalalgia 2019; 39 (7): 803-16
Sacco S, Benemei S, Cevoli S, Coppola G, Cortelli P, De Cesaris F, De Icco R, De Marco CM, Di Lorenzo C, Geppetti P, Manni A, Negro A, Ornello R, Pierangeli G, Pierelli F, Pellesi L, Pini LA, Pistoia F, Prudenzano MP, Russo A, Sances G, Taranta V, Tassorelli C, Tedeschi G, Trojano M, Martelletti P. Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraine. J Headache Pain 2019; 20 (1): 15
Bottiroli S, Galli F, Viana M, De Icco R, Bitetto V, Allena M, Pazzi S, Sances G, Tassorelli C. Negative Short-Term Outcome of Detoxification Therapy in Chronic Migraine With Medication Overuse Headache: Role for Early Life Traumatic Experiences and Recent Stressful Events. Front Neurol 2019; 10: 173
Jellestad PL, Carlsen LN, Westergaard ML, Munksgaard SB, Bendtsen L, Lainez M, Fadic R, Katsarava Z, Goicochea MT, Spadafora S, Jensen RH, Nappi G, Tassorelli C; COMOESTAS Consortium. Economic benefits of treating medication-overuse headache - results from the multicenter COMOESTAS project. Cephalalgia 2019; 39 (2): 274-285.
Bottiroli S, Allena M, Sances G, De Icco R, Avenali M, Fadic R, Katsarava Z, Lainez MJ, Goicochea MT, Bendtsen L, Jensen RH, Nappi G, Tassorelli C; COMOESTAS Consortium. Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project. Cephalalgia 2019; 39 (1): 135-47
Cargnin S, Viana M, Sances G, Cantello R, Tassorelli C, Terrazzino S. Using a Genetic Risk Score Approach to Predict Headache Response to Triptans in Migraine Without Aura. J Clin Pharmacol 2019; 59 (2): 288-94
Demartini C, Greco R, Zanaboni AM, Sances G, De Icco R, Borsook D, Tassorelli C. Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back. Prog Neurobiol 2019; 177:15-32
Tassorelli C, Greco R, Silberstein SD.The endocannabinoid system in migraine: from bench to pharmacy and back. Curr Opin Neurol 2019; 32(3):405-41
Antonaci F, Rossi E, Voiticovschi-Iosob C, Dalla Volta G, Marceglia S. Frontal infrared thermography in healthy individuals and chronic migraine patients: Reliability of the method. Cephalalgia 2018;
Ion I, Renard D, Le Floch A, De Verdal M, Bouly S, Wacongne A, Lozza A, Castelnovo G. Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine. Toxins (Basel) 2018; 10 (6)
Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Dorlas S, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P; PRESTO Study Group. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study. Neurology 2018; 91(4):e364-e373.
Tassorelli C, Tedeschi G, Sarchielli P, Pini LA, Grazzi L, Geppetti P, De Tommaso M, Aguggia M, Cortelli P, Martelletti P.Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life. Expert Rev Neurother 2018; 18 (2): 167-76
Termine C, Bartoli B, Agosti MA, Cavanna AE, Balottin U. Cognitive Impairment in Children and Adolescents With Migraine. Front Neurol 2018; 9: 66
Balottin L, Mannarini S, Candeloro D, Mita A, Chiappedi M, Balottin U. Rorschach Evaluation of Personality and Emotional Characteristics in Adolescents With Migraine Versus Epilepsy and Controls. Front Neurol 2018; 9: 160
Jellestad PL, Carlsen LN, Westergaard ML, Munksgaard SB, Bendtsen L, Lainez M, Fadic R, Katsarava Z, Goicochea MT, Spadafora S, Jensen RH, Nappi G, Tassorelli C; COMOESTAS Consortium. Economic benefits of treating medication-overuse headache - results from the multicenter COMOESTAS project. Cephalalgia 2018; 1:333102418786265
Bottiroli S, Allena M, Sances G, De Icco R, Avenali M, Fadic R, Katsarava Z, Lainez MJ, Goicochea MT, Bendtsen L, Jensen RH, Nappi G, Tassorelli C; COMOESTAS Consortium. Psychological, clinical, and therapeutic predictors of the outcome of detoxification in a large clinical population of medication-overuse headache: A six-month follow-up of the COMOESTAS Project. Cephalalgia 2018;
Viana M, Bottiroli S, Sances G, Ghiotto N, Allena M, Guaschino E, Nappi G, Tassorelli C. Factors associated to chronic migraine with medication overuse: A cross-sectional study. Cephalalgia 2018; 38(14):2045-57
Grieco GS, Gagliardi S, Ricca I, Pansarasa O, Neri M, Gualandi F, Nappi G, Ferlini A, Cereda C. New CACNA1A deletions are associated to migraine phenotypes. J Headache Pain 2018; 19 (1): 75
Grazzi L, Tassorelli C, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P; PRESTO Study Group. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain. 2018; 19 (1): 98
Demartini C, Greco R, Zanaboni AM, Francesconi O, Nativi C, Tassorelli C, Deseure K. Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model. Int J Mol Sci 2018; 19 (11)
Martelletti P, Barbanti P, Grazzi L, Pierangeli G, Rainero I, Geppetti P, Ambrosini A, Sarchielli P, Tassorelli C, Liebler E, de Tommaso M; PRESTO Study Group. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 2018; 19 (1): 101
Viana M, Sances G, Linde M, Nappi G, Khaliq F, Goadsby PJ, Tassorelli C. Prolonged migraine aura: new insights from a prospective diary-aided study. J Headache Pain 2018; 19 (1): 7
Bottiroli S, Galli F, Viana M, Sances G, Tassorelli C. Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse. Front Psychol 2018; 9: 704
Antonaci F, Fredriksen T, Pareja JA, Sjaastad O. Shortlasting, Unilateral, Neuralgiform, Headache Attacks With Conjunctival Injection, Tearing, Sweating and Rhinorrhea: The Term and New View Points. Front Neurol 2018; 9: 262
Sprenger T, Viana M, Tassorelli C. Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action. Neurotherapeutics 2018; 15(2):313-323
Steiner TJ, Buse DC, Al Jumah M, Westergaard ML, Jensen RH, Reed ML, Prilipko L, Mennini FS, Láinez MJA, Ravishankar K, Sakai F, Yu SY, Fontebasso M, Al Khathami A, MacGregor EA, Antonaci F, Tassorelli C, Lipton RB; Lifting The Burden: The Global Campaign against Headache. The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility. J Headache Pain 2018; 19 (1): 15
Tassorelli C, Diener HC, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ; International Headache Society Clinical Trials Standing Committee. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. Cephalalgia 2018; 38(5):815-32
Viana M, Sances G, Terrazzino S, Sprenger T, Nappi G, Tassorelli C. When cervical pain is actually migraine: An observational study in 207 patients. Cephalalgia 2018; 38(2); 383-8
Viana M, Afridi S. Migraine with prolonged aura: phenotype and treatment. Naunyn Schmiedebergs Arch Pharmacol 2018; 391 (1): 1-7
Scuteri D, Crudo M, Rombolà L, Watanabe C, Mizoguchi H, Sakurada S, Sakurada T, Greco R, Corasaniti MT, Morrone LA, Bagetta G. Antinociceptive effect of inhalation of the essential oil of bergamot in mice. Fitoterapia 2018; 129:20-24.
Greco R, Demartini C, Zanaboni AM, Tassorelli C. Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing. J Headache Pain. 2018 Jul 13;19(1):51
Greco R, Demartini C, Zanaboni AM, Piomelli D, Tassorelli C. Endocannabinoid System and Migraine Pain: An Update. Front Neurosci. 2018 Mar 19;12:172
Evers S, Wang SJ, Tassorelli C. Board Walk - April 2017. Cephalalgia 2017; 37 (4): 401-40
De Icco R, Martinelli D, Bitetto V, Fresia M, Liebler E, Sandrini G, Tassorelli C. Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study. Cephalalgia. 2017 Jan 1:333102417742347
Cargnin S, Viana M, Sances G, Tassorelli C, Terrazzino S. A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache. Cephalalgia 2017;  doi: 10.1177/0333102417728244
Bottiroli S, Allena M, Sances G, De Icco R, Avenali M, Fadic R, Katsarava Z, Lainez MJ, Goicochea MT, Jensen RH, Nappi G, Tassorelli C; Comoestas Consortium. Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project. Cephalalgia 2017; doi: 10.1177/0333102417704415
Viana M, Sances G, Terrazzino S, Sprenger T, Nappi G, Tassorelli C. When cervical pain is actually migraine: An observational study in 207 patients. Cephalalgia 2017; OI: https://doi.org/10.1177/0333102416660549
Tassorelli C, Sances G, Avenali M, De Icco R, Martinelli D, Bitetto V, Nappi G, Sandrini G. Botulinum toxin for chronic migraine: Clinical trials and technical aspects. Toxicon 2017; DOI: https://doi.org/10.1177/0333102416678000
Greco R, Demartini C, Zanaboni AM, Redavide E, Pampalone S, Toldi J, Fülöp F, Blandini F, Nappi G, Sandrini G, Vécsei L, Tassorelli C. Effects of kynurenic acid analogue 1 (KYNA-A1) in nitroglycerin-induced hyperalgesia: Targets and anti-migraine mechanisms. Cephalalgia 2017; 37(13):1272-84
Tassorelli C, Jensen R, Allena M, De Icco R, Katsarava Z, Miguel Lainez J, Leston JA, Fadic R, Spadafora S, Pagani M, Nappi G. The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study. Cephalalgia 2017; 37(12):1115-1125
Tassorelli C, Tramontano M, Berlangieri M, Schweiger V, D'Ippolito M, Palmerini V, Bonazza S, Rosa R, Cerbo R, Buzzi MG. Assessing and treating primary headaches and cranio-facial pain in patients undergoing rehabilitation for neurological diseases. J Headache Pain 2017; 18 (1): 99
Demartini C, Tassorelli C, Zanaboni AM, Tonsi G, Francesconi O, Nativi C, Greco R. The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model. J Headache Pain 2017; 18 (1): 94
Ambrosini A, D'Onofrio M, Buzzi MG, Arisi I, Grieco GS, Pierelli F, Santorelli FM, Schoenen J. Possible Involvement of the CACNA1E Gene in Migraine: A Search for Single Nucleotide Polymorphism in Different Clinical Phenotypes. Headache. 2017 Jul;57(7):1136-44
Perrotta A, Anastasio MG, De Icco R, Coppola G, Ambrosini A, Serrao M, Sandrini G, Pierelli F. Frequency-Dependent Habituation Deficit of the Nociceptive Blink Reflex in Aura With Migraine Headache. Can Migraine Aura Modulate Trigeminal Excitability? Headache 2017; 57(6):887-898
Tassorelli C, Aguggia M, De Tommaso M, Geppetti P, Grazzi L, Pini LA, Sarchielli P, Tedeschi G, Martelletti P, Cortelli P. Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers. J Headache Pain 2017; 18 (1):66
Galli F, Caputi M, Sances G, Vegni E, Bottiroli S, Nappi G, Tassorelli C. Alexithymia in chronic and episodic migraine: a comparative study. J Ment Health 2017; 26 (3): 192-6
Viana M, Sances G, Linde M, Ghiotto N, Guaschino E, Allena M, Terrazzino S, Nappi G, Goadsby PJ, Tassorelli C. Clinical features of migraine aura: Results from a prospective diary-aided study. Cephalalgia 2017; 37 (10): 979-89
Miglino B, Viana M, Tiberio R, Boggio P, Valente G, Strigaro G, Colombo E. POEMS syndrome: a rare case report. Giornale italiano di dermatologia e venereologia 2017; 152(5): 531-3
Terrazzino S, Cargnin S, Viana M, Sances G, Tassorelli C. Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism Impacts on Migraine Susceptibility: A Meta-analysis of Case-Control Studies. Front Neurol. 2017; 8: 159
Tassorelli C. The Grand Challenge in Cranial Pain-From Migraine to Cranial Neuralgias: Understanding Differences and Similarities to Advance Knowledge and Management. Front Neurol 2017; 8:19
Schankin CJ, Viana M, Goadsby PJ. Persistent and Repetitive Visual Disturbances in Migraine: A Review. Headache 2017; 57(1):1-16

Non era il Centro che cercavi?

Cerca un altro Centro Cefalee nelle vicinanze:

Tutti i Centri Cefalee in Lombardia Tutti i Centri Cefalee a Pavia

Contatti
SISC - Società Italiana per lo Studio delle Cefalee
Registro Persone Giuridiche - Prefettura di Firenze - n. 534/2011
  • Indirizzo:
    Viale Pieraccini, 18
    50139 Firenze FI
    P.IVA 05057860487
    C.F. 01529430488
  • Telefono: 075 585 8181 (dal lunedì al giovedì: orario: 8:30 - 13:00) Società Scientifica - non effettua visita per cefalee
  • Fax: 075 578 4229
  • Email: sisc@sisc.it
Cerca nel sito

Inserisci le parole di tuo interesse e seleziona il pulsante "Cerca"

Newsletter SISC

Iscriviti alla nostra newsletter per ricevere aggiornamenti e novità sulle attività SISC

© 2014. SISC Società Italiana per lo Studio delle Cefalee. All rights reserved. Partita IVA 05057860487 - Codice Fiscale 01529430488
Tutela della privacy - Informativa sui cookie - I miei consensi